-- 周二午盘交易中,受伊朗和平协议乐观情绪提振,原油期货价格走低,以及大型银行公布季度财报的影响,美国股市指数上涨。 纳斯达克综合指数上涨1.4%,至23,515.6点;标普500指数上涨0.9%,至6,948.1点;道琼斯工业平均指数上涨0.6%,至48,523.3点。 据美国有线电视新闻网(CNN)援引知情人士报道,如果特朗普总统认为伊朗准备接受他的要求,他仍然愿意尽快恢复面对面谈判。一位知情人士告诉CNN,特朗普政府官员正在内部讨论在4月21日停火协议到期前与伊朗官员举行第二次面对面会晤的细节。 据一位知情人士向CNN透露,周六在伊斯兰堡,美国谈判代表提议伊朗暂停铀浓缩活动20年。CNN援引一位美国官员的话报道称,伊朗回应称暂停五年,但遭到美国拒绝。 西德克萨斯中质原油期货价格下跌5.9%,至每桶93.21美元;布伦特原油期货价格下跌3.4%,至每桶95.98美元。 多数美国国债收益率下跌,其中10年期国债收益率下跌2.5个基点至4.27%,2年期国债收益率下跌1.3个基点至3.77%。 公司方面,花旗集团(C)和贝莱德(BLK)公布的第一季度盈利和营收增长均超出市场预期。摩根大通(JPM)的第一季度业绩也好于预期。
Related Articles
Dongjiang Environmental's Loss Widens 2.7% in Q1
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
Zuoli Kechuang Logs Drop in Q1 Profit
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.